Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Elixir's reports results from phase III trial of metformin-mitiglinide therapy

Nov. 21, 2008

FDA reschedules Advisory Committee meeting with Novo for liraglutide until April 2009

Nov. 21, 2008

Phase I trials confirm excellent tolerance of GFT-505 in healthy volunteers

Nov. 20, 2008

Metabolex presents results from phase II MBX-8025 trial

Nov. 20, 2008

Agile's lead product, AG-200-15, moves into pivotal phase III trials

Nov. 20, 2008

JUPITER study: Rosuvastatin beneficial in patients with normal cholesterol but elevated CRP

Nov. 19, 2008

Recent Pfizer patent describes novel treatments for lipoprotein disorders

Nov. 19, 2008

New contraceptive agents reported in recent Addex patent

Nov. 19, 2008

Medgenics encouraged by preliminary results with EPODURE in phase I/II study

Nov. 19, 2008

New compounds for hypogonadism described in recent GSK patent

Nov. 18, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...